Was the Nation Watching Side Effects Unfold? Dr. Quay Analyzes President Biden’s Health

Did Prostate Cancer Treatment Shape What We Saw in President Biden?

Dr. Steven Quay recently joined Real America’s Voice to help the public better understand former President Biden’s reported diagnosis of advanced prostate cancer. Drawing on his extensive experience as a physician, researcher, and expert in cancer diagnostics, Dr. Quay explained that prostate cancer is often a slow-moving disease. In most cases, it develops quietly over five to seven years before reaching an advanced stage.

As you’ll hear during the interview, for men over 40, early detection is usually straightforward. Simple screening tools like the PSA blood test and a digital rectal exam can catch prostate cancer long before it causes major symptoms. That is why it is unusual for someone in their eighties to suddenly be diagnosed with late-stage disease, as most cases would have shown warning signs much earlier.

The discussion also covered the effects of treatment, specifically therapies that block testosterone. While these treatments can be effective, they often bring challenging side effects. Many patients experience a loss of muscle strength, a higher risk of falls, and changes in memory or thinking. These are real concerns that can have a significant impact on daily life.

One of the most thought-provoking parts of the conversation centered on the possibility that some of President Biden’s widely observed stumbles and changes in cognition could reflect the side effects of prostate cancer treatment. Dr. Quay was careful to say that this remains speculation, not a medical diagnosis. However, he stressed that it is important for the public to consider these questions, especially when the health of national leaders is so closely tied to public confidence.

Dr. Quay’s message was clear: early detection and honest conversations about health matter, whether you are a patient, a family member, or a leader on the world stage. Staying informed and proactive can make all the difference when it comes to cancer care.

 

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Watch Dr. Steven Quay’s interview on America at Night as he discusses genetic privacy, public health reform, and the ethics of gain-of-function research. Learn more and preorder Dr. Quay’s new book, The Code as Witness.

Dr. Steven Quay joins Fox News to discuss President Biden’s advanced prostate cancer diagnosis, the importance of early detection, and what this means for patients and families. Learn more about the medical facts, treatment options, and why regular screening matters.

On National Women’s Checkup Day, Dr. Steven Quay shares practical advice on the importance of regular checkups, early detection, and preventive care for women’s health. Watch Dr. Quay’s KFYR TV interview for tips on breast cancer prevention and staying healthy all year.